Real-world before-and-after evaluation of AI support for lung cancer diagnosis at three US lung nodule clinics
Lee, K. A.; Borah, A.; Fiscus, G.; Petricca PA-C, L.; Dean, S.; Rings, A.; Santos, C.; Pickup, L. C.; Ibrahim, O.
Show abstract
BackgroundHealth systems and payers require evidence that artificial intelligence (AI)-enabled decision support improves care delivery. Integrating AI into lung nodule management pathways may streamline workflows, improve identification and triage of patients with pulmonary nodules, and enable earlier lung cancer diagnosis. Yet real-world evidence of clinical utility remains limited. This study evaluated the impact of implementing a commercially available AI software to support the lung nodule and lung cancer care pathway across three US health systems. Materials and MethodsA real-world before-and-after study compared clinic activity during matched 12.5-month pre-implementation and post-implementation periods at three US lung nodule clinics. Primary outcomes were the number of new patients and the number of invasive procedures performed. Secondary outcomes were numbers of lung cancers and early-stage (stages 0-II) lung cancers, and time from baseline CT to diagnosis. Analyses used Wilcoxon signed-rank and Mann-Whitney U tests, with medians and interquartile ranges (IQRs) reported for continuous measures. ResultsAcross sites, new patients increased from 138 before to 232 after implementation, equivalent to 11.0 to 18.6 patients per month (p=0.0002), with the median rising from 9 (IQR 7-14) to 16 (IQR 13-21) patients. Monthly invasive procedures increased from 5.0 to 7.8 (p=0.0093). Monthly cancers increased from 3.0 to 3.8 (p=0.3242), while monthly early-stage cancers rose from 1.4 to 2.4 (p=0.0996). Median time to diagnosis was 58 days (IQR 33-153) before and 57 days (IQR 27-85) after implementation (p=0.28), with IQR narrowing from 120 days to 58 days. ConclusionImplementation of the AI-enabled software was associated with significantly increased patient throughput resulting in an increase in lung cancer diagnoses. These results, observed prospectively post-implementation, suggest AI-assisted identification and triage can expand access to timely specialist review while maintaining diagnostic efficiency.
Matching journals
The top 5 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Accuracy of deep learning based computed tomography diagnostic system of COVID-19: a consecutive sampling external validation cohort study 91%
- Navigated ultrasound bronchoscopy with integrated positron emission tomography - A human feasibility study 90%
- Classification performance bias between training and test sets in a limited mammography dataset 90%
Similar papers in this journal
- Evaluation of an artificial intelligence model for detection of pneumothorax and tension pneumothorax on chest radiograph 92%
- Low adherence to existing model reporting guidelines by commonly used clinical prediction models 91%
- Missing data in the medical record for oncology patients: prevalence and association with outcomes 90%
Similar papers in this journal
- Theory of radiologist interaction with instant messaging decision support tools: a sequential-explanatory study 92%
- Development and Validation of a Deep Learning Model for Detecting Signs of Tuberculosis on Chest Radiographs among US-bound Immigrants and Refugees 92%
- A Comparison of CXR-CAD Software to Radiologists in Identifying COVID-19 in Individuals Evaluated for Sars CoV 2 Infection in Malawi and Zambia 90%
Similar papers in this journal
- Diagnostic accuracy of three computer-aided detection systems for detecting pulmonary tuberculosis on chest radiography when used for screening: analysis of an international, multicenter migrants screening study 91%
- Self-tests for COVID-19: what is the evidence? A living systematic review and meta-analysis (2020-2023) 90%
- Accuracy of digital chest x-ray analysis with artificial intelligence software as a triage and screening tool in hospitalized patients being evaluated for tuberculosis in Lima, Peru 90%
Similar papers in this journal
- User Testing of a Diagnostic Decision Support System with Machine-assisted Chart Review to Facilitate Clinical Genomic Diagnosis 89%
- Development of a customised data management system for a COVID-19-adapted colorectal cancer pathway 88%
- The performance of national COVID-19 ‘Symptom Checkers’: A comparative case simulation study 88%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.